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Abstract
Arterial stiffness, often measured by carotid–femoral pulse wave velocity (cfPWV), is a subclinical marker of 
cardiovascular disease that is known to be reduced by exercise training. Exercise is also known to have acute vascular 
effects, yet it is unclear whether exercise 24 h before cfPWV testing influences this outcome. Thirty healthy, young 
adults completed a supervised, 30-min bout of moderate-to-vigorous intensity treadmill running. cfPWV, systolic 
blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were measured both before (after 48 h of 
abstaining from exercise) and 24 h after (with no additional exercise) the exercise session. From pre-exercise to 24 h 
post exercise, cfPWV decreased from 6.05 ± 0.82 to 5.84 ± 0.87 m s− 1 (P = 0.02), SBP from 119.7 ± 13.8 to 116.8 ± 
11.4 mm Hg (P = 0.03) and DBP from 65.1 ± 5.7 to 63.2 ± 5.4 mm Hg(P = 0.02), with no significant changes in HR. 
cfPWV was positively correlated with SBP pre-exercise (r = 0.54, Po0.01) and post exercise (r = 0.53, Po0.01). Changes 
in blood pressure explained 4–5% of the variability in cfPWV change; adjustments slightly attenuated the 24-h effects 
of exercise on cfPWV. Some evidence of gender differences was observed with higher cfPWV in males across 
assessments (Po0.05) and statistically significant reductions in cfPWV in males (−0.36 ± 0.54 m s − 1 (P = 0.02)) but 
not in females (−0.07 ± 0.31 m s − 1 (P = 0.41)). In conclusion, cfPWV decreased 24 h after an exercise bout, 
suggesting that exercise completed in the past 24 h should be considered before cfPWV testing.
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Arterial stiffness, often measured by carotid–femoral pulse wave velocity (cfPWV), is a subclinical marker of cardiovascular 
disease that is known to be reduced by exercise training. Exercise is also known to have acute vascular effects, yet it is unclear 
whether exercise 24 h before cfPWV testing influences this outcome. Thirty healthy, young adults completed a supervised, 30-
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(P = 0.02), SBP from 119.7 ± 13.8 to 116.8 ± 11.4 mm Hg (P = 0.03) and DBP from 65.1 ± 5.7 to 63.2 ± 5.4 mm Hg
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post exercise (r = 0.53, Po0.01). Changes in blood pressure explained 4–5% of the variability in cfPWV change; adjustments 
slightly attenuated the 24-h effects of exercise on cfPWV. Some evidence of gender differences was observed with higher cfPWV 
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INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death worldwide,
and it is projected to remain the leading cause of death by 2030.1,2 It is
well established that aerobic exercise reduces CVD risk2 by reducing
CVD risk factors, including blood pressure and arterial stiffness.3–5 In
addition to chronic training adaptations, exercise is known to have
acute benefits on blood pressure immediately and up to 24 h post
exercise.6,7 However, whether exercise has a similar effect on arterial
stiffness 24 h after an exercise bout is not well studied.
Carotid–femoral pulse wave velocity (cfPWV) is the non-invasive,
gold-standard method for assessing arterial stiffness.8 Vascular testing
protocols, including cfPWV, typically instruct subjects to refrain from
activities that could introduce measurement error (for example,
smoking, caffeine and eating) before testing.4,8 Some vascular testing
protocols (for example, arterial compliance and flow-mediated
dilation) also instruct subjects to refrain from exercise preceding the
assessment because of the potential transient effects of exercise on
vascular function.9,10 Although it is known that exercise acutely
increases arterial compliance,11 several cfPWV consensus statements
do not recommend that subjects refrain from exercise before
testing.8,12,13 Few studies have evaluated ‘next-day’ effects of exercise
on arterial stiffness with varied results; however, most studies have
been small and have used heterogeneous methods.14–17 Further, these
studies have not examined the effects by gender, although gender is
known to have an effect on arterial stiffness.18 Determining whether
transient changes in cfPWV are present 24 h after exercise is important
for reducing potential variability during vascular testing procedures.
Thus, the purpose of this study was to examine the effects of a 30-min
bout of treadmill running at a moderate-to-vigorous intensity on
cfPWV after 24 h. We hypothesized that a single exercise session
would decrease cfPWV. Secondary objectives were to evaluate whether
this effect differed by gender or was related to concomitant changes in
resting blood pressure or resting HR.
METHODS
Participants
Thirty healthy men (N= 15) and women (N= 15), 18–35 years old,
volunteered to participate in the study (Table 1). Recruitment was completed
through advertisements, with most of the sample comprising students and staff
of the University of Pittsburgh. Written informed consent was obtained for all
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subjects before experimental procedures. Approval for this study was granted by
the Institutional Review Board at the University of Pittsburgh.
Exclusion criteria were pre-established and included any medical condition
or medication affecting energy metabolism or cardiovascular response, history
of cardiac events or conditions, current pregnancy, obesity (body mass index
(kg m− 2) ⩾ 30 kg m−2), high-risk classification according to the American
College of Sports Medicine criteria19 or a self-reported inability to run for
30 min.
Experimental procedures
Each participant visited the laboratory on three separate occasions. During the
first workload estimation visit, a treadmill speed needed to elicit the desired
heart rate (HR) for a moderate-to-vigorous intensity bout (70–75% of age-
predicted maximum HR) was determined. Participants began with a 5-min
warm-up at a speed of 3.0 miles per hour (mph) at 0% grade, after which the
speed was increased to 5.0. If the target HR was not reached by the third
minute, the speed was increased by 0.5 mph every 3 min until the target HR
was achieved.
The second exercise session visit occurred a minimum of 2 days after the first
visit, as participants were instructed to refrain from exercise for 48 h.
Participants were also instructed to fast for 12 h before the second visit and
verbal confirmation of protocol compliance was obtained. During this visit,
cfPWV was measured, after which the participant performed the exercise
session. The exercise session included a 5-min warm-up at 3.0 mph, 30 min of
moderate-to-vigorous intensity treadmill running and a 5-min cool down at
3.0 mph. To achieve the targeted moderate-to-vigorous intensity, the 30-min
exercise bout was initiated at the predetermined workload from the first visit.
Thereafter, the HR was monitored with a Polar monitor and the treadmill
speed was adjusted by ± 0.2 mph if the last minute of each 5-min interval was
either above or below the 70–75% age-predicted maximum HR. Using this
method, participants achieved average HRs during the exercise sessions of
73.0± 4.9% of age-predicted maximum HR.
Before the third visit, which occurred 24 h later, participants were instructed
to refrain from any additional exercise and fast for 12 h. This was confirmed
before cfPWV testing.
Assessments
Anthropometrics. Height and weight were measured with the participant
wearing lightweight clothing and no shoes. Weight was measured to the
nearest 0.1 kg on a Tanita WB 110A digital scale, and height was measured to
the nearest 0.1 cm using a stadiometer. Body mass index was computed from
weight and height.
Pulse wave velocity. cfPWV was measured using the Complior Analyse
(Alam Medical; Vincennes, France) on the right side of the body by a trained
technician between 0700 and 1000 hours. Subjects laid supine for a 10-min rest
period before cfPWV measurement.8 Using a tape measure, aortic distance was
estimated by subtracting the distance from the carotid artery site to the sternal
notch from the distance of the sternal notch to the femoral artery site.5,12,20
Piezoelectric sensors were held in place to obtain 10 valid waveforms. This
process was repeated until three runs of 10 waveforms were captured. Average
cfPWV (m s− 1) was calculated as aortic distance divided by the average time
differential between the foot of the waveform at the carotid and femoral sites
within each run, and then averaged across the three runs. Inter-rater reliability
of technicians in our laboratory ranged from 85 to 96% in 2014.
Resting blood pressure and HR. Systolic blood pressure (SBP), diastolic blood
pressure (DBP) and HR measurements were obtained after a 10-min supine
rest immediately before and following cfPWV testing with an automated
Dinamap V100 (GE Healthcare, Pittsburgh, PA, USA). Pre- and post-cfPWV
measurements were averaged for analysis.
Statistical analysis
All variables were evaluated for normality. Our sample size (n= 30) was
calculated to provide 90% power to detect an effect size of 0.5 for the change in
cfPWV, assuming a correlation of r= 0.5 from pre- to post-exercise within
individuals and a type I error rate of 0.05. Descriptive statistics were
summarized overall and by gender with means (s.d.'s) and compared across
genders by two-sided independent t-tests. Effect sizes were calculated using
Cohen’s d formula.21 Equality of variance across groups was confirmed with
Levene’s test. Changes in cfPWV, SBP, DBP and HR were evaluated using two-
sided paired t-tests. Pearson’s correlations between changes in cfPWV and
changes in SBP, DBP and HR were examined to evaluate potential mechanisms
through which exercise might influence cfPWV. Linear regression was used to
examine whether changes in cfPWV were independent of changes in SBP, DBP
and HR in separate models.11,22–24 The coefficient of determination (R2) was
calculated to describe common variance between the change in cfPWV and
changes in SBP, DBP and HR. A 2×2 factorial analysis of variance was used to
evaluate a gender x exercise interaction, and equality of covariance matrices was
confirmed by Box’s test. Error bars were calculated as s.e.m.
RESULTS
Twenty-four-hour post-exercise changes in outcomes
The sample had a mean age of 24± 3 years and a mean body mass
index of 23.7± 2.2 kg m−2 (Table 1). These were similar in males and
females. Pre- and post-exercise outcomes are displayed in Table 2.
Overall, cfPWV, SBP and DBP significantly decreased 24 h post
exercise from baseline (Po0.05). The mean cfPWV decreased from
6.05± 0.82 to 5.84± 0.87 m s− 1 (P= 0.02), with an effect size of 0.26.
Because one subject had a large decrease in cfPWV (−1.90 m s− 1), we
repeated analyses using a non-parametric related samples Wilcoxon-
signed rank test and found similar results (P= 0.01). Results were also
similar when we repeated the paired t-test after excluding this subject
(−0.16± 0.33 m s− 1, P= 0.02). Individual changes in cfPWV 24 h post
exercise are displayed by gender in Figure 1. The mean SBP decreased
from 119.7± 13.8 to 116.8± 11.4 mmHg (P= 0.03), with an effect
Table 1 Characteristics of participants (n=30)
Characteristic Overall Male Female
Age (years) 23.8±2.5 23.4±1.8 24.3± 3.0
Weight (kg) 68.9±9.9 73.8±6.6a 63.9±10.3a
Height (cm) 170.3±8.4 175.8±6.4a 164.7±6.3a
BMI (kg m−2) 23.7±2.2 23.9±1.7 23.4±2.6
Abbreviation: BMI, body mass index.
Data are presented as mean± s.d.
aSignificant gender differences Po0.01.
Table 2 Pre-exercise, 24-h post-exercise and 24-h change in outcomes
Measure Pre-exercise 24-h post-exercise Change P-value
Pulse wave velocity (m s−1) 6.05±0.82 5.84±0.87 −0.22±0.46 0.02
Systolic blood pressure (mm Hg) 119.7±13.8 116.8±11.4 −2.90±6.8 0.03
Diastolic blood pressure (mm Hg) 65.1±5.7 63.2±5.4 −1.88±4.3 0.02
Heart rate (bpm) 62.1±10.0 61.6±10.9 −0.55±6.7 0.65
Abbreviations: BP, blood pressure; bpm, beats per minute.
Data are presented as mean± s.d.
size of 0.21; DBP decreased from 65.1± 5.7 to 63.2± 5.4 mmHg
(P= 0.02), with an effect size of 0.33. HR did not change (P= 0.65).
Gender differences
Pre- and post-exercise outcomes by gender are displayed in Table 3.
Figures 1 and 2 illustrate gender differences in cfPWV. The mean
cfPWV in men was 12% higher pre-exercise and 8% higher
post-exercise when compared with their female counterparts
(main effect of gender F= 4.30; P= 0.047). The mean post-exercise
cfPWV was reduced by 0.36 (P= 0.02; 5.6%) in males and 0.07
(P= 0.41; 1.2%) in females. The gender × exercise interaction failed to
reach statistical significance (F= 3.38; P= 0.08). SBP was also higher
in males; however, changes in SBP as well as DBP and HR were similar
across genders.
Correlations
cfPWV was correlated with SBP pre-exercise (r= 0.544, Po0.01) and
post-exercise (r= 0.529, Po0.01), and the magnitude of the correla-
tion was higher in females. Furthermore, the change in SBP was
correlated with change in cfPWV only in females (r= 0.525, Po0.05).
cfPWV was not significantly correlated with pre-exercise, post-exercise
or change in DBP. Although pre-exercise and post-exercise HR were
not significantly correlated with cfPWV, change in HR was correlated
with change in cfPWV only in males (0.541, Po0.01; Table 4).
Changes in cfPWV were adjusted for changes in SBP, DBP and HR in
separate models. Changes in SBP, DBP and HR explained 5.2%, 4.1%
and 9.8% of the variability in cfPWV change, respectively. The 24-h
effects of exercise on cfPWV were attenuated to − 0.17 (P= 0.06) after
adjustment for changes in SBP, to − 0.18 (P= 0.06), after adjustment
for changes in DBP, and to − 0.20 (P= 0.02), after adjustment for
changes in HR (Table 4).
DISCUSSION
The main finding of the present study is that cfPWV had a small, but
significant, decrease 24 h post exercise in a group of healthy, young
adults. This was accompanied by significant decreases in resting SBP
and DBP. Changes in blood pressure explained a small proportion of
the variability in changes in cfPWV. Males had a higher cfPWV both
pre- and post exercise and had a significantly decreased post-exercise
cfPWV, whereas females did not.
Few studies have evaluated the effect of exercise on arterial
compliance 24 h post exercise, and these have yielded mixed
results.14–17 Our results are similar to a study by Michaelides
et al.,15 where cfPWV was reduced 24 h after a 30-min bout of
walking in 60 older adults with a mean age of 61.4 ± 1.0 years.15 Three
other studies found no effect of exercise on arterial compliance.14,16,17
Kingwell et al. found no change in cfPWV among 12 young adult
males (24± 6 years) 24 h after a 30-min bout of cycling at 65% of
maximal oxygen consumption (VO2 max).
17 Aizawa et al.14 found no
difference in carotid and brachial arterial distensibility using high-
resolution ultrasound in nine hypertensive older individuals
(68.2± 5.4 years) 24 h after a maximal treadmill exercise test.14 Nickle
et al.16 found no difference in large and small arterial compliance
using Diastolic Pulse Contour Analysis in 32 older individuals
(71± 7 years) 24 h after a 30-min bout of cycling at 50% VO2
max.16 Although not statistically significant, Nickle et al.16 demon-
strated that both large and small arterial elasticity increased
(improved) 24 h following exercise. The different results could be
attributed to small sample sizes, different methodologies used to
measure arterial stiffness, different experimental exercise protocols and
differences in participant characteristics.
Other studies have evaluated more proximal (for example, 30 min
after) and longer-term (for example, ⩾ 1 month) effects of exercise on
arterial stiffness, typically showing a benefit. Arterial stiffness has been
observed to decrease immediately after,25 and between 2 and 60 min
after aerobic exercise.16,17,26–29 Aerobic training studies of longer
duration (6 days to 8 months) have also reduced arterial
stiffness.30–36
Several physiological mechanisms could contribute to the 24-h
reduction in cfPWV observed in the current study. Exercise increases
the requirements of the muscle for oxygen and nutrients, therefore
increasing blood flow and shear stress, both of which raise the
production of nitric oxide.11 Nitric oxide is a potent vasodilator,
reducing vascular smooth muscle cell tone,11,29 which transfers stress
from collagen fibers to elastin.17,37 This shift increases arterial
compliance and decreases cardiac load due to elastin’s crucial role in


























Figure 1 Changes in carotid–femoral pulse wave velocity 24 h post exercise.
Each bar represents the change in carotid–femoral pulse wave velocity
(cfPWV) from pre- to 24 h post-exercise in each participant. Black bars
represent females and gray bars represent males.





Pulse wave velocity (m s−1)
Male 6.42±0.83a 6.06±0.99 −0.36±0.54 0.02
Female 5.69±0.64a 5.62±0.70 −0.07±0.31 0.41
Systolic blood pressure
(mm Hg)
Male 127.4±12.4a 123.9±7.7a −3.5±7.9 0.11
Female 112.1±10.8a 109.7±10.0a −2.3±5.8 0.14
Diastolic blood pressure
(mm Hg)
Male 65.0±6.2 62.8±5.5 −2.2±4.1 0.06
Female 65.2±5.3 63.6±5.4 −1.6±4.6 0.21
Heart rate (bpm)
Male 63.0±9.6 63.2±10.1 0.23±8.1 0.91
Female 61.3±10.7 60.0±11.8 −1.3±5.1 0.33
Abbreviations: BP, blood pressure; bpm, beats per minute.
Data are presented as mean± s.d.
aSignificant gender differences Po0.05.
expression of other vasodilators, vasoconstrictors, inflammatory med-
iators, reactive oxygen species or antioxidants may contribute.11
Consistent with these mechanisms, SPB and DBP are reduced at
30 min as well as 24 h following exercise,7 the latter of which was
measured and observed in the current study. Other studies have found
that changes in blood pressure do not appear to be fully responsible
for changes in cfPWV.27 This was also consistent with our study,
which found that controlling for changes in SBP and DBP only slightly
attenuated the effects of exercise on cfPWV and explained 4–5% of the
variability in changes in cfPWV.
Repeated bouts of exercise over time are also believed to benefit
cfPWV through structural vascular adaptations.17 Chronic increases in
the blood flow and shear stress during exercise induce a larger vessel
diameter,39 better endothelial function,2 increased antioxidant enzyme
activity, improved physiological function and enhanced systemic
resistance to oxidative stress.40 These changes are thought to benefit
arterial compliance, consequently reducing risk for CVD. Although we
would not expect these chronic benefits to contribute to the 24-h
decreases in cfPWV observed in this study, these adaptations are likely
additive to the transient effects of exercise because we observed a 24-h
effect among young, healthy volunteers who self-reported an ability to
run for 30 min. Thus, chronic and acute transient effects may
contribute to the benefit of exercise on arterial stiffness.
The overall gender differences found in our study are consistent
with Mitchell et al. who found that males had a higher cfPWV
compared with their female counterparts.41 These gender differences
could be due to differences in estrogen receptor-alpha on smooth
muscle cells,42 differences in hormone and endothelin-1 production or
differences in resting blood pressure between males and females.26
Despite gender differences in cfPWV, the effect of exercise on cfPWV
was not statistically different by gender (gender × exercise interaction,
F= 3.38; P= 0.08). However, this trend might have reached statistical
significance with a larger sample size and, within gender, the decrease
in cfPWV was only statistically significant in males. One potential
reason for the greater reduction in cfPWV among males is that,
although intensity was controlled, males ran at a significantly
higher speed during their exercise session compared with females
(5.4 vs. 4.9 mph, P= 0.036). Another potential explanation could be
that males in our study had higher pre-exercise cfPWV. Lower cfPWV
in females could have resulted in a ‘floor’ effect, where there was little
room for further reductions, and could have contributed to the more
pronounced 24-h decrease in cfPWV in males compared with females.
Whether these gender differences would persist in a study population
with stiffer or more comparable arteries is an area of further research.
One implication of our results is that exercise performed up to 24 h
before cfPWV testing in a research or clinical setting should be
considered. Although small, the systematic decrease we observed could
introduce error. For example, a testing protocol could require patients
to refrain from exercise at least 24 h before cfPWV testing. Viewed
another way, our findings in healthy, young adults suggest that regular
bouts of exercise (for example, on most days of the week) could be
important to realize the maximum acute and chronic benefits on
arterial stiffness and cardiovascular health in this population.
The present study has a number of strengths. Arterial stiffness was
measured by cfPWV, which is the gold standard,8 exercise sessions
were supervised to standardize intensity and there was a sufficient
sample size to detect small changes in 24-h cfPWV. Some limitations
should be considered. Our study used a single-arm pre-post design,
and thus our results are hypothesis-generating and should be
interpreted cautiously. Of note, because some participants may have
been unfamiliar with the cfPWV procedure, ‘white coat’ effects
resulting in an increased sympathetic tone could have been stronger
in the pre-exercise compared with the post-exercise assessments and
may have contributed to the observed differences.8,43,44 In addition,



















Figure 2 Gender differences in carotid–femoral pulse wave velocity
pre-exercise and 24 h post exercise. The mean carotid–femoral pulse wave
velocity (cfPWV; ± s.e.m.) for men was higher when compared with their
female counterparts (main effect of gender F=4.30; P=0.047). There was
a significant decrease in cfPWV from pre- to post exercise (main effect of
exercise F=7.28; P=0.012). Males had a larger reduction in post-exercise
cfPWV compared with females, the gender × exercise interaction, however,
failed to reach statistical significance (F=3.38; P=0.077).
Table 4 Correlations and changes in cfPWV adjusted for changes in blood pressure and heart rate
Measure Pre-exercise (r) 24-h post-exercise (r) Change (r) Adjusted change in cfPWV (m s−1)a R2a
Systolic blood pressure (mm Hg) 0.544** 0.529** 0.227 0.172 5.2%
Male 0.199 0.216 0.078 — —
Female 0.680* 0.837** 0.525* — —
Diastolic blood pressure (mm Hg) 0.329 0.316 0.203 0.176 4.1%
Male 0.427 0.462 0.213 — —
Female 0.296 0.190 0.178 — —
Heart rate (bpm) 0.276 0.248 0.313 0.204* 9.8%
Male 0.386 0.170 0.541* — —
Female 0.137 0.292 -0.068 — —
Abbreviations: bpm, beats per minute; cfPWV, carotid–femoral pulse wave velocity; DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure.
* Po0.05.
**Po0.01.
aResults from separate linear regression models with change in cfPWV as the dependent variable and change in SBP, DBP or HR as the independent variable.
our results cannot be generalized to populations other than young,
healthy adults.
In conclusion, arterial stiffness decreased 24 h following a moderate-
to-vigorous bout of exercise in young, healthy adults. These findings
are important to consider for standardization of cfPWV testing
protocols and, potentially, realizing a maximal benefit of exercise on
cardiovascular health through regular rather than sporadic exercise
bouts. Future studies should investigate the effects of exercise on
cfPWV in other populations (for example, older, unfit or obese, with
varying intensities or durations of exercise) and evaluate the combined
contribution of acute and chronic effects of exercise on cfPWV.
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